NASDAQ:MOLN Molecular Partners Q2 2026 Earnings Results & Report $2.53 -0.13 (-4.89%) Closing price 03:58 PM EasternExtended Trading$2.53 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Molecular Partners beat analyst earnings expectations in its Q2 2026 results, released August 24, 2026. The company reported EPS of -$0.44 versus the -$0.45 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 24, 2026TimeBefore Market OpensConference Call DateAugust 25, 2026Conference Call3:00 AM ET Molecular Partners EPS ResultsActual EPS-$0.44Consensus EPS -$0.45Beat/MissBeat by +$0.01One Year Ago EPSN/AEPS Beat Rate4 of last 8 quartersMolecular Partners Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesSlide DeckPress Release (6-K)Earnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Earnings DocumentsPress Release(6-K) Molecular Partners Q2 2026 Earnings FAQ Did Molecular Partners beat earnings estimates for Q2 2026? Molecular Partners (NASDAQ:MOLN) reported earnings of -$0.44 per share for Q2 2026, beating the consensus estimate of -$0.45. The report was announced on Monday, August 24, 2026. Molecular Partners Earnings HeadlinesMolecular Partners to Present at Inaugural UBS Global Biopharma ConferenceNovember 13, 2026 | globenewswire.comMolecular Partners Presents New Preclinical Data for Next-Generation T Cell Engager MP0632 at SITC 2026November 6, 2026 | globenewswire.comWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.November 20 at 1:00 AM | Porter & Company (Ad)Molecular Partners to Present on DLL3-Targeting Radio-DARPin MP0712 at 2026 SNMMI Theranostics Conference and NACLC 2026November 5, 2026 | globenewswire.comSwiss biotech firm Molecular Partners to cut nearly half of workforceOctober 29, 2026 | msn.comMolecular Partners Reports Q3 2026 Financial Results, Deepens Focus on Targeted RadiotherapyOctober 29, 2026 | globenewswire.comSee More Molecular Partners Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Molecular Partners? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Molecular Partners and other key companies, straight to your email. Email Address About Molecular PartnersMolecular Partners (NASDAQ:MOLN) is a Swiss biotechnology company that develops protein-based medicines using its proprietary DARPin platform. Designed ankyrin repeat proteins, or DARPins, are engineered to bind specific biological targets and can be developed to act on one or several targets. The company’s research focuses on therapeutic candidates for cancer and other serious diseases. Its pipeline has included treatments designed to engage immune cells against tumors and to target proteins found in the tumor environment. Founded in 2004 as a spin-off from the University of Zurich, Molecular Partners is headquartered in Schlieren, Switzerland. Co-founder Patrick Amstutz has served as its chief executive officer, and the company has pursued research and development through its own programs and collaborations with other biotechnology and pharmaceutical companies.View Molecular Partners ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItAirfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter TestHard Drives Were Left for Dead, But Seagate and Western Digital Are SoaringPalo Alto Networks' Q1 Beat Gives Its Stock Rally Another Reason to RunGrand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.